You are here: Industry Insights > COVID-19

News List

Eiger BioPharmaceuticals Announces First Patients Dosed with Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients prnewswire
July 07, 2021
Eiger BioPharmaceuticals, Inc. today announced that the first patients were dosed with Peginterferon Lambda (Lambda) in the Phase 3 TOGETHER platform study in outpatients with COVID-19.
Ongoing pharma productivity requires a focus on upskilling europeanpharmaceuticalreview
July 06, 2021
Research suggests that if pharma does not address staff capability gaps and support employee training and development, then there will be a significant impact on productivity.
Over 600,000 COVID-19 tests genomically sequenced in the UK pharmatimes
July 06, 2021
The UK has sequenced over 600,000 positive COVID-19 tests, providing ‘invaluable data’ in the fight against the virus, the Department of Health and Social Care (DHSC) announced last Friday.
Study finds rise in antibiotic misuse in India during COVID first wave expresspharma
July 06, 2021
The researchers estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses of azithromycin in adults from June 2020 through September 2020.
ICMR-NICED submits proposal to DBT for research on oral COVID-19 vaccine expresspharma
July 06, 2021
It will take around five to six years to develop the oral vaccine in a laboratory, said Shanta Dutta, Director, ICMR-NICED.
India's COVID Crisis Could Spawn Another: Antibiotic Misuse drugs
July 06, 2021
While COVID-19 surged in India, so did the overuse or widespread misuse of antibiotics -- risking a future threat of drug-resistant bacteria.
Researchers find potential path to a broadly protective COVID-19 vaccine using T cells firstwordpharma
July 06, 2021
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.
Ministry data said to show Pfizer shot blocks majority of serious Delta cases firstwordpharma
July 06, 2021
A study from researchers at Hebrew University and Hadassah University Medical Center suggest Pfizer and BioNTech's COVID-19 vaccine is 60% to 80% effective against infection from the Delta variant, reported The Times of Israel.
Gap between Covid jabs to be reduced to eight weeks for all under-40s firstwordpharma
July 06, 2021
New UK health secretary Sajid Javid told lawmakers "we are reducing the dose interval [for COVID-19 vaccines] for under-40s from 12 weeks to eight," as reported in This is Money.
France's Sanofi expects Covid vaccine to be ready by December firstwordpharma
July 06, 2021
Sanofi says its GlaxoSmithKline-partnered COVID-19 vaccine should be available by December, reported RFI. The vaccine uses recombinant proteins to trigger an immune response – the same technology that is used in one of Sanofi's seasonal influenza vaccines

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page